KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Assets (2016 - 2025)

Historic Return on Assets for Ionis Pharmaceuticals (IONS) over the last 16 years, with Q3 2025 value amounting to 0.09%.

  • Ionis Pharmaceuticals' Return on Assets rose 400.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.15% for FY2024, which is 200.0% down from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Return on Assets is 0.09%, which was up 400.0% from 0.09% recorded in Q2 2025.
  • Ionis Pharmaceuticals' Return on Assets' 5-year high stood at 0.0% during Q3 2022, with a 5-year trough of 0.25% in Q3 2021.
  • Its 5-year average for Return on Assets is 0.12%, with a median of 0.12% in 2023.
  • In the last 5 years, Ionis Pharmaceuticals' Return on Assets crashed by -2800bps in 2021 and then skyrocketed by 2500bps in 2022.
  • Over the past 5 years, Ionis Pharmaceuticals' Return on Assets (Quarter) stood at 0.01% in 2021, then crashed by -831bps to 0.11% in 2022, then decreased by -14bps to 0.12% in 2023, then decreased by -21bps to 0.15% in 2024, then surged by 43bps to 0.09% in 2025.
  • Its Return on Assets was 0.09% in Q3 2025, compared to 0.09% in Q2 2025 and 0.16% in Q1 2025.